EP 1360191 A2 20031112 - METHODS AND COMPOSITIONS FOR EXPRESSING POLYNUCLEOTIDES SPECIFICALLY IN SMOOTH MUSCLE CELLS IN VIVO
Title (en)
METHODS AND COMPOSITIONS FOR EXPRESSING POLYNUCLEOTIDES SPECIFICALLY IN SMOOTH MUSCLE CELLS IN VIVO
Title (de)
"VERFAHREN UND ZUSAMMENSETZUNGEN ZUR IN-VIVO-EXPRESSION VON POLYNUKLEOTIDEN, SPEZIFISCH IN GLATTEN MUSKELZELLEN"
Title (fr)
PROCEDES ET COMPOSITIONS POUR L'EXPRESSION DE POLYNUCLEOTIDES SPECIFIQUEMENT DANS DES CELLULES DE MUSCLE LISSE IN VIVO
Publication
Application
Priority
- US 0202016 W 20020124
- US 26381101 P 20010124
Abstract (en)
[origin: WO02059270A2] The present invention generally relates to promoters, enhancers and other regulatory elements of smooth muscle cells ("SMC"). The invention more particularly relates to methods for the targeted knockout, or over-expression, of genes of interest within smooth muscle cells or within a subtype of smooth muscle cells. The invention further relates to methods of conferring polynucleotide expression in vivo specifically in smooth muscle cells or in subtypes of smooth muscle cells.
IPC 1-7
IPC 8 full level
C12N 15/85 (2006.01); A61K 48/00 (2006.01)
CPC (source: EP)
C12N 15/85 (2013.01); A01K 2217/05 (2013.01); A61K 48/00 (2013.01); C12N 2830/008 (2013.01); C12N 2830/85 (2013.01); C12N 2840/44 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02059270 A2 20020801; WO 02059270 A3 20030327; WO 02059270 A8 20031106; AU 2002237928 A1 20020806; CA 2435631 A1 20020801; EP 1360191 A2 20031112; EP 1360191 A4 20040825
DOCDB simple family (application)
US 0202016 W 20020124; AU 2002237928 A 20020124; CA 2435631 A 20020124; EP 02704234 A 20020124